Standout Papers

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitor... 1998 2026 2007 2016 3.4k
  1. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL (1998)
    Hisataka Yasuda, Nobuyuki Shima et al. Proceedings of the National Academy of Sciences
  2. Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche (2004)
    Fumio Arai, Atsushi Hirao et al. Cell
  3. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells (2006)
    Keisuke Ito, Atsushi Hirao et al. Nature Medicine
  4. Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesisin Vitro1 (1998)
    Hisataka Yasuda, Nobuyuki Shima et al. Endocrinology
  5. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells (2004)
    Keisuke Ito, Atsushi Hirao et al. Nature
  6. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. (1990)
    Nobuyuki Udagawa, N. Takahashi et al. Proceedings of the National Academy of Sciences
  7. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. (1981)
    Chisato Miyaura, Hiroshi Sakagami et al. Proceedings of the National Academy of Sciences
  8. Metabolic requirements for the maintenance of self-renewing stem cells (2014)
    Keisuke Ito, Toshio Suda Nature Reviews Molecular Cell Biology
  9. DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells (2005)
    Mitsuru Yagi, Takeshi Miyamoto et al. The Journal of Experimental Medicine
  10. Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells (2010)
    Keiyo Takubo, Nobuhito Goda et al. Cell stem cell
  11. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression (1993)
    Dale I. Godfrey, Jacqueline Kennedy et al. The Journal of Immunology
  12. Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin (1998)
    Atsuko Mizuno, Norio Amizuka et al. Biochemical and Biophysical Research Communications
  13. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. (1991)
    Akira Yamaguchi, Takenobu Katagiri et al. The Journal of Cell Biology
  14. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow (2009)
    Satoru Morikawa, Yo Mabuchi et al. The Journal of Experimental Medicine
  15. Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis (1997)
    Toshio Suda, Masaaki Goto et al. Biochemical and Biophysical Research Communications
  16. Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche (2011)
    Toshio Suda, Keiyo Takubo et al. Cell stem cell
  17. Regulation of Glycolysis by Pdk Functions as a Metabolic Checkpoint for Cell Cycle Quiescence in Hematopoietic Stem Cells (2013)
    Keiyo Takubo, Go Nagamatsu et al. Cell stem cell
  18. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis (2006)
    Chen Zhao, Naoko Irie et al. Cell Metabolism
  19. Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors (1999)
    Fumio Arai, Takeshi Miyamoto et al. The Journal of Experimental Medicine
  20. Thrombopoietin/MPL Signaling Regulates Hematopoietic Stem Cell Quiescence and Interaction with the Osteoblastic Niche (2007)
    Hiroki Yoshihara, Fumio Arai et al. Cell stem cell
  21. A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance (2012)
    Keisuke Ito, Arkaitz Carracedo et al. Nature Medicine
  22. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. (1988)
    Yoshiko Yamaguchi, Toshio Suda et al. The Journal of Experimental Medicine
  23. Osteoclast differentiation by RANKL and OPG signaling pathways (2020)
    Nobuyuki Udagawa, Masanori Koide et al. Journal of Bone and Mineral Metabolism
  24. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine (1971)
    H. F. DeLuca, Michael F. Holick et al. Biochemistry
  25. Biological Activity of 25-Hydroxyergocalciferol in Rats (1970)
    Toshio Suda, Hector F. DeLuca et al. Journal of Nutrition

Immediate Impact

7 by Nobel laureates 58 from Science/Nature 152 standout
Sub-graph 1 of 13

Citing Papers

A molecular atlas of cell types and zonation in the brain vasculature
2018 StandoutNature
Autophagy maintains stemness by preventing senescence
2016 StandoutNature
3 intermediate papers

Works of Toshio Suda being referenced

Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
2006 Standout
Differentiation of Arterial and Venous Endothelial Cells and Vascular Morphogenesis
2006
and 3 more

Author Peers

Author Last Decade Papers Cites
Toshio Suda 31977 10128 11801 16318 723 57.6k
David T. Scadden 18435 13644 10234 10085 382 42.8k
Roderick T. Bronson 45554 3607 11362 22954 543 76.8k
Tak W. Mak 49026 3791 33684 22375 703 94.7k
Tadamitsu Kishimoto 21971 8705 33603 25455 633 76.3k
Carl‐Henrik Heldin 41421 3775 5864 13948 492 62.1k
Erwin F. Wagner 33303 1612 7459 14036 356 49.9k
H. Phillip Koeffler 22103 6990 5528 9803 660 41.3k
Napoleone Ferrara 60705 3192 9980 20350 257 97.7k
Anita B. Roberts 31347 1820 6187 10283 286 52.9k
Ronald A. DePinho 55409 2838 9669 22760 416 84.9k

All Works

Loading papers...

Rankless by CCL
2026